How are CYP2D6 and sleep related?

The relationship between CYP2D6 and sleep is indirect and not well-established. CYP2D6 is an enzyme primarily involved in metabolizing many drugs, including some that can affect sleep (e.g., certain antidepressants, antipsychotics, or melatonin). Genetic variants in CYP2D6 can alter the metabolism of these substances, which could theoretically influence sleep quality or duration. However, there are no robust studies directly linking CYP2D6 polymorphisms to sleep parameters such as sleep onset or architecture. The available evidence is mostly mechanistic or from pharmacogenetic studies, not from sleep-specific research. Therefore, using a direct-to-consumer DNA test for CYP2D6 variants to optimize sleep is not evidence-based. Sleep issues should be addressed with validated methods like sleep diaries, actigraphy, or clinical evaluation. The utility of DTC tests in this context is limited.